Literature DB >> 10639456

Impact of heterogeneity within cultured cells on bacterial invasion: analysis of Pseudomonas aeruginosa and Salmonella enterica serovar typhi entry into MDCK cells by using a green fluorescent protein-labelled cystic fibrosis transmembrane conductance regulator receptor.

A A Gerçeker1, T Zaidi, P Marks, D E Golan, G B Pier.   

Abstract

The cystic fibrosis transmembrane conductance regulator (CFTR) is a chloride ion channel that also serves as a receptor for entry of Pseudomonas aeruginosa and Salmonella enterica serovar Typhi into epithelial cells. To evaluate heterogeneity in CFTR protein expression in cultured cells and the effect of heterogeneity on internalization of different P. aeruginosa and serovar Typhi strains, we used two-color flow cytometry and confocal laser microscopy to study bacterial uptake by Madin-Darby canine kidney (MDCK) type I epithelial cells stably expressing a green fluorescent protein (GFP)-CFTR fusion construct (MDCK-GFP-CFTR cells). We found a strong correlation between cell size and GFP-CFTR protein expression, with 60 to 70% of cells expressing low levels of GFP-CFTR protein, 20 to 30% expressing intermediate levels, and <10% expressing high levels. The cells were sorted into low-, intermediate-, or high-level producers of CFTR protein; in vitro growth of each sorted population yielded the same distribution of CFTR protein expression as that in the original population. Cells expressing either low or high levels of CFTR protein internalized bacteria poorly; maximal bacterial uptake occurred in the cells expressing intermediate levels of CFTR protein. Treatment of MDCK cells with sodium butyrate markedly enhanced the production of CFTR protein without increasing cell size; butyrate treatment also increased the proportion of cells with internalized bacteria. However, there were fewer bacteria per butyrate-treated cell and, for P. aeruginosa, there was an overall decrease in the total level of bacterial uptake. The most highly ingested bacterial strains were internalized by fewer total MDCK-GFP-CFTR cells, indicating preferential bacterial uptake by a minority of epithelial cells within a given culture. Confocal fluorescence microscopy showed that P. aeruginosa and serovar Typhi induced cytoplasmic accumulation of CFTR protein close to the plasma membrane where the bacteria were adherent. These results show that within a population of MDCK-GFP-CFTR cells, there are cells with markedly different abilities to ingest bacteria via CFTR, the majority of the P. aeruginosa and serovar Typhi cells are ingested by the one-fourth to one-third of the cells that exhibit an intermediate size and level of CFTR protein expression, and overexpression of the CFTR receptor does not increase total bacterial uptake but rather allows more epithelial cells to ingest fewer total bacteria.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10639456      PMCID: PMC97215          DOI: 10.1128/IAI.68.2.861-870.2000

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  21 in total

1.  Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 8-1999. A 28-year-old man with gram-negative sepsis of uncertain cause.

Authors: 
Journal:  N Engl J Med       Date:  1999-03-18       Impact factor: 91.245

2.  Epithelial cell polarity affects susceptibility to Pseudomonas aeruginosa invasion and cytotoxicity.

Authors:  S M Fleiszig; D J Evans; N Do; V Vallas; S Shin; K E Mostov
Journal:  Infect Immun       Date:  1997-07       Impact factor: 3.441

3.  How mutant CFTR may contribute to Pseudomonas aeruginosa infection in cystic fibrosis.

Authors:  G B Pier; M Grout; T S Zaidi; J B Goldberg
Journal:  Am J Respir Crit Care Med       Date:  1996-10       Impact factor: 21.405

4.  Butyrate increases apical membrane CFTR but reduces chloride secretion in MDCK cells.

Authors:  B D Moyer; D Loffing-Cueni; J Loffing; D Reynolds; B A Stanton
Journal:  Am J Physiol       Date:  1999-08

5.  Pili binding to asialo-GM1 on epithelial cells can mediate cytotoxicity or bacterial internalization by Pseudomonas aeruginosa.

Authors:  J C Comolli; L L Waite; K E Mostov; J N Engel
Journal:  Infect Immun       Date:  1999-07       Impact factor: 3.441

6.  Use of sodium butyrate to enhance production of retroviral vectors expressing CFTR cDNA.

Authors:  J C Olsen; J Sechelski
Journal:  Hum Gene Ther       Date:  1995-09       Impact factor: 5.695

7.  Role of mutant CFTR in hypersusceptibility of cystic fibrosis patients to lung infections.

Authors:  G B Pier; M Grout; T S Zaidi; J C Olsen; L G Johnson; J R Yankaskas; J B Goldberg
Journal:  Science       Date:  1996-01-05       Impact factor: 47.728

8.  Efficient endocytosis of the cystic fibrosis transmembrane conductance regulator requires a tyrosine-based signal.

Authors:  L S Prince; K Peter; S R Hatton; L Zaliauskiene; L F Cotlin; J P Clancy; R B Marchase; J F Collawn
Journal:  J Biol Chem       Date:  1999-02-05       Impact factor: 5.157

Review 9.  Intracellular CFTR: localization and function.

Authors:  N A Bradbury
Journal:  Physiol Rev       Date:  1999-01       Impact factor: 37.312

10.  Functional activation of the cystic fibrosis trafficking mutant delta F508-CFTR by overexpression.

Authors:  S H Cheng; S L Fang; J Zabner; J Marshall; S Piraino; S C Schiavi; D M Jefferson; M J Welsh; A E Smith
Journal:  Am J Physiol       Date:  1995-04
View more
  11 in total

1.  Characterization of an ExoS Type III translocation-resistant cell line.

Authors:  Elizabeth A Rucks; Joan C Olson
Journal:  Infect Immun       Date:  2005-01       Impact factor: 3.441

2.  Measuring activity of endocytosis-regulating factors in T-lymphocytes by flow cytometry.

Authors:  Violeta Beltran-Sastre; Estanislau Navarro
Journal:  Cytotechnology       Date:  2014-02-07       Impact factor: 2.058

3.  Influence of cystic fibrosis transmembrane conductance regulator on gene expression in response to Pseudomonas aeruginosa infection of human bronchial epithelial cells.

Authors:  Nina Reiniger; Jeffrey K Ichikawa; Gerald B Pier
Journal:  Infect Immun       Date:  2005-10       Impact factor: 3.441

4.  Salmonella enterica serovar typhi modulates cell surface expression of its receptor, the cystic fibrosis transmembrane conductance regulator, on the intestinal epithelium.

Authors:  Jeffrey B Lyczak; Gerald B Pier
Journal:  Infect Immun       Date:  2002-11       Impact factor: 3.441

Review 5.  Role of the cystic fibrosis transmembrane conductance regulator in innate immunity to Pseudomonas aeruginosa infections.

Authors:  G B Pier
Journal:  Proc Natl Acad Sci U S A       Date:  2000-08-01       Impact factor: 11.205

6.  Pseudomonas aeruginosa-mediated damage requires distinct receptors at the apical and basolateral surfaces of the polarized epithelium.

Authors:  Iwona Bucior; Keith Mostov; Joanne N Engel
Journal:  Infect Immun       Date:  2009-12-14       Impact factor: 3.441

7.  Novel adenoviral vectors coding for GFP-tagged wtCFTR and deltaF508-CFTR: characterization of expression and electrophysiological properties in A549 cells.

Authors:  Horia Vais; Guang-Ping Gao; Michael Yang; Phoi Tran; Jean-Pierre Louboutin; Suryanarayan Somanathan; James M Wilson; William W Reenstra
Journal:  Pflugers Arch       Date:  2004-12       Impact factor: 3.657

8.  Cystic fibrosis transmembrane conductance regulator and caveolin-1 regulate epithelial cell internalization of Pseudomonas aeruginosa.

Authors:  Milan Bajmoczi; Mihaela Gadjeva; Seth L Alper; Gerald B Pier; David E Golan
Journal:  Am J Physiol Cell Physiol       Date:  2009-04-22       Impact factor: 4.249

Review 9.  Pseudomonas aeruginosa lipopolysaccharide: a major virulence factor, initiator of inflammation and target for effective immunity.

Authors:  Gerald B Pier
Journal:  Int J Med Microbiol       Date:  2007-04-27       Impact factor: 3.473

10.  GFP-tagged CFTR transgene is functional in the G551D cystic fibrosis mouse colon.

Authors:  D Oceandy; B McMorran; R Schreiber; B J Wainwright; K Kunzelmann
Journal:  J Membr Biol       Date:  2003-04-01       Impact factor: 1.843

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.